A Study of DCC-2701 in Participants With Advanced Solid Tumors

Clinical trial NCT02228811 · TERMINATED

Trial details

NCT number: NCT02228811
Sponsor: Deciphera Pharmaceuticals, LLC
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Locally Advanced Tumors Metastatic Solid Tumors Cancers With MET Genomic Alterations Cancers With TRK Genomic Alterations

Start date: 2014-06-01
Primary completion: 2017-11-01
Enrollment: 44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.